Core Viewpoint - Pomerantz LLP is investigating potential securities fraud and unlawful business practices by Bright Horizons Family Solutions Inc. following a significant decline in the company's financial performance and an increase in expected center closures [1]. Financial Performance - Bright Horizons reported a net income of $22 million for the fourth quarter of 2025, representing a 25% decrease year-over-year [1]. - The diluted earnings per common share were $0.38, down 24% compared to the previous year [1]. - The decline in financial performance was primarily attributed to $14.8 million in impairment and lease termination costs related to facility closures [1]. Operational Changes - The company announced an expected closure of "45 to 50 or so centers" in 2026, nearly doubling its prior estimate of "25 to 30 or so centers" [1]. - This operational change is likely to impact future revenue and profitability [1]. Market Reaction - Following the announcement of the financial results and center closures, Bright Horizons' stock price fell by $14.93 per share, or 18.25%, closing at $66.90 per share on February 13, 2026 [1].

Core Viewpoint - A class action lawsuit has been filed against BellRing Brands, Inc. for alleged securities fraud and unlawful business practices [2][4]. Group 1: Lawsuit Details - The class action lawsuit involves allegations that BellRing and certain officers and/or directors engaged in securities fraud or other unlawful business practices [2]. - Investors have until March 23, 2026, to request to be appointed as Lead Plaintiff if they purchased BellRing securities during the Class Period [2]. Group 2: Financial Performance and Stock Impact - On May 6, 2025, BellRing disclosed that customers were "hoarding inventory," which would slow sales growth in the third quarter to "low-single-digits," resulting in a stock price drop of $14.88 per share, or 18.97%, closing at $63.55 [4]. - On August 4, 2025, BellRing reported its third-quarter financial results and narrowed its fiscal year 2025 outlook for net sales, leading to a stock price decline of $17.46 per share, or nearly 33%, closing at $36.18 [5].

Core Viewpoint - A class action lawsuit has been filed against Bath & Body Works, Inc. concerning allegations of securities fraud and unlawful business practices [2]. Financial Performance - Bath & Body Works reported a second quarter 2025 earnings per diluted share of $0.30, a decline of 55.8% year over year, and net income of $64 million, down 57.9% year over year [4]. - The company cut its full year guidance for earnings per diluted share by $0.03, adjusting it to a range of $3.28 to $3.53 [4]. - In the third quarter of 2025, Bath & Body Works experienced a 1% year over year decline in revenue, missing its guidance of 1-3% growth [6]. - Net income for the third quarter fell 26% to $77 million, and the company revised its full year guidance for net sales from a previously positive outlook to negative "high single digits" [6]. - Expected earnings per diluted share were cut from a range of $3.28 to $3.53 to "at least $2.83" [6]. Stock Performance - Following the second quarter results, Bath & Body Works' stock price fell by $2.18 per share, or 6.9%, closing at $29.36 [5]. - After the third quarter results, the stock price dropped by $5.22 per share, or 24.8%, closing at $15.82 [6]. Legal Context - Investors have until March 16, 2026, to request appointment as Lead Plaintiff in the class action if they purchased Bath & Body Works securities during the Class Period [2].

Core Viewpoint - Pomerantz LLP is investigating potential securities fraud or unlawful business practices involving Align Technology, Inc. and its officers or directors, following disappointing financial results and a significant stock price drop [1][3]. Financial Performance - Align Technology reported total revenues of approximately $1.01 billion for Q2 2025, which was below both consensus estimates and the company's own guidance [3]. - The company lowered its revenue guidance for Q3 and full-year growth expectations, attributing this to economic uncertainty and reduced demand for its products [3]. - Following the announcement, Align's stock price fell by $74.56 per share, or 36.63%, closing at $129.01 per share on July 31, 2025 [3]. Legal Investigation - The investigation by Pomerantz LLP is aimed at determining if Align and its executives engaged in any fraudulent activities that may have misled investors [1]. - Pomerantz LLP is recognized for its expertise in corporate, securities, and antitrust class litigation, having a long history of fighting for victims of securities fraud [4].

Core Viewpoint - A class action lawsuit has been filed against Broadmark Realty Capital Inc. for alleged securities fraud and unlawful business practices related to a merger [2][3]. Group 1: Lawsuit Details - The lawsuit claims that Broadmark's proxy statement for the merger contained false or misleading statements and failed to disclose critical financial distress among borrowers in Ready Capital's portfolio due to high interest rates [3]. - It is alleged that an oversupply of multifamily properties in Ready Capital's markets limited borrowers' ability to raise rents to cover growing debt costs [3]. - A significant development project acquired during the merger, valued at approximately $500 million, faced catastrophic setbacks, including cost overruns and construction delays [3]. - The lawsuit asserts that Ready Capital's Current Expected Credit Loss reserves and expected credit losses were materially understated, impacting financial projections regarding Distributable Earnings per share, dividends per share, and book value per share [3]. Group 2: Legal Representation - Pomerantz LLP, a firm recognized for its expertise in corporate, securities, and antitrust class litigation, is representing the class in this lawsuit [4].

Core Viewpoint - Centene Corporation is facing potential legal claims regarding violations of federal securities laws and unlawful business practices following a significant drop in stock price after withdrawing its 2025 earnings guidance [1][2]. Group 1: Company Performance - On July 2, 2025, Centene's stock price fell over 39.5% during intraday trading after the company announced the withdrawal of its 2025 earnings guidance due to higher-than-expected costs related to Medicaid enrollees and underperformance in its Affordable Care Act plans [2]. - The company indicated that its Medicaid business has seen an increase in medical cost trends in areas such as behavioral health, home health, and high-cost drugs [2]. Group 2: Legal Investigation - Bragar Eagel & Squire, P.C. is investigating potential claims against Centene on behalf of its stockholders, focusing on whether the company has violated federal securities laws [1]. - The law firm is reaching out to long-term stockholders who may have suffered losses or have information regarding these claims [3].

Core Viewpoint - Metallus Inc. is under investigation for potential securities fraud and unlawful business practices following disappointing financial results for Q1 2025, which led to a significant drop in stock price [1][3]. Financial Performance - Metallus reported non-GAAP earnings per share of $0.07 for Q1 2025, missing consensus estimates by $0.05 [3]. - The company's stock price fell by $1.48, or 11.31%, closing at $11.61 per share on May 9, 2025, following the earnings announcement [3]. Company Challenges - The CEO of Metallus indicated that the company experienced volatility in the defense supply chain during Q1 2025, attributed to customer manufacturing start-up challenges [3].

Core Viewpoint - Bragar Eagel & Squire, P.C. is investigating potential claims against Tempus AI, Inc. regarding possible violations of federal securities laws and other unlawful business practices [1][2] Group 1: Investigation and Claims - The investigation by Bragar Eagel & Squire, P.C. is on behalf of Tempus stockholders [1] - Spruce Point Capital Management published a report raising concerns about Tempus, including aggressive accounting practices and the background of several board members with troubled companies [2] - Following the report, Tempus's stock price experienced a significant decline during intraday trading on May 28, 2025 [2] Group 2: Company Background - Tempus AI, Inc. is publicly traded on NASDAQ under the ticker symbol TEM [2] - Bragar Eagel & Squire, P.C. is a law firm that represents individual and institutional investors in various types of litigation [4]